Align Technologyvs.Boston Scientific
ALGN vs BSX · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Boston Scientific is about 6.1× larger than Align Technology by market cap; Boston Scientific trades at the lower P/E (20.4 vs 29.9); year to date, Align Technology leads (+2.2% vs −48.6%).
Side by side
| ALGN | BSX | |
|---|---|---|
| Market cap | $12.3B | $75B |
| Price | $159.61 | $49.86 |
| Today | −0.0% | +1.7% |
| Return YTD | +2.2% | −48.6% |
| Return 1Y | +6.7% | −53.8% |
| P/E | 29.9 | 20.4 |
| P/S | 3.0 | 3.6 |
| P/B | 2.9 | 3.0 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
Align TechnologyALGN
Invisalign clear aligners, backed by digital dental scanning.
Full ALGN profile →Boston ScientificBSX
Cardiology drives the growth, particularly electrophysiology, where Farapulse sits, and structural heart treatment. Endoscopy and urology cover the rest of the range.
Full BSX profile →More ALGN & BSX comparisons
Other head-to-heads in the Medtech & devices segment.
See where ALGN and BSX sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →